Grifols, S.A.

GRFSNASDAQHealthcare● Active

$7.41

$-0.24(-3.08%)

Market Cap$6.3B

P/E Ratio—

52W High$11.14

52W Low$7.39

Avg Volume727K

Open$7.56

Beta1.17

Free Cash Flow Financials Revenue

Grifols, S.A. (GRFS) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

GRFS · free cash flow · updated Jun 8, 2026

Core FCF metrics

GRFS · FCF · TTM · margin & CAGR

Free cash flow was $751.1M for FY2025 (fiscal year ending 2025-12-31), up 41.5% year-over-year The FCF margin was 10.4%. Five-year CAGR stands at -2.0%.

FY2025 Free Cash Flow$751.1M▲ +41.5% YoY

Trailing 12M (TTM)$744.5Mtrailing 4 quarters sum

FCF Margin10.4%$751.1M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGR-2.0%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

GRFS · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$1.01B(255M)$751.1M▲ +41.5%10.4%

FY2024$902.2M(371M)$530.8M▲ +679.3%7.4%

FY2023$218.7M(310M)−$91.6M▲ +76.3%-1.4%

FY2022−$10.9M(376M)−$386.4M▼ 210.5%-6.4%

FY2021$597.0M(247M)$349.6M▼ 57.9%7.1%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

GRFS · P/FCF · FCF yield · FCF per share

Grifols, S.A. (GRFS) trades at a FCF yield of 12.26% and a price-to-free-cash-flow ratio of 6.8x. FCF per share stands at $1.09, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

12.26%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$1.09

TTM FCF ÷ Shares Outstanding

Price / FCF

x6.8

Share Price ÷ FCF per Share

EV / FCF (TTM)

x20.1

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

GRFS · cash flow statement · operating / investing / financing

For FY2025, Grifols, S.A. generated $1.01B in operating cash flow and spent 255M in capital expenditures, yielding $751.1M in free cash flow.

Operating Activities

+$1.01B

Cash from core business operations

2025-12-31

Investing Activities

−$556.1M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$508.1M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($1.01B) − |CapEx| (255M) = FCF ($751.1M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

GRFS vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Grifols, S.A.YOU

GRFS

$751.1M+41.5%10.4%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Grifols, S.A. (GRFS) reported free cash flow of $751.1M for FY2025 (fiscal year ending 2025-12-31), up 41.5% year-over-year. The FCF margin was 10.4%.

Based on available data, Grifols, S.A. has maintained positive free cash flow for at least 13 fiscal year(s). FCF peaked at $830.2M in FY2020. The 5-year CAGR stands at -2.0%.

Grifols, S.A.'s FCF yield is 12.26% and price-to-FCF ratio is 6.8x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

GRFS free cash flow · 8 questions

Grifols, S.A. free cash flow was $751.1M for FY2025, up 41.5% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $744.5M.

GRFS free cash flowGRFS FCFGRFS FCF 2025GRFS free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Grifols, S.A. · Grifols, S.A. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026